About PACE Align
Partnering for Continuity.
PACE Align is the intelligence and accountability layer for patient support programmes across biologics and long-term specialty injectable therapies in Saudi Arabia. It connects enrolment, treatment-rhythm signals, persistence-risk prediction, PSP delivery and programme outcomes across chronic, recurring treatment pathways. Pharmaceutical teams receive de-identified programme intelligence, while authorised PSP teams use the information needed to coordinate support and resolve patient needs.

What PACE stands for
- PPatients
- AAdherence
- CCompliance
- EExcellence
Built for Saudi healthcare transformation

Digital health
Turn enrolment, treatment-rhythm signals, persistence risk, PSP intervention and outcomes into governed programme intelligence.
Quality & efficiency
Prioritise support, reduce manual coordination, track resolution and help teams use programme capacity more effectively.
Earlier intervention & continuity
Identify emerging persistence risk before avoidable treatment interruption and support continuity throughout the treatment journey.
Integrated care & private-sector innovation
Strengthen coordinated, role-based collaboration across pharma, PSPs and healthcare partners while keeping programme intelligence consistent and measurable.
Building the intelligence infrastructure for treatment continuity.
PSP partnership
Operational collaboration, workflow enablement and measurable performance evidence that strengthens delivery without replacing the PSP role.
Technology & integration
Interoperability, data exchange and deployment partnerships that connect PACE with existing healthcare and enterprise systems.
Healthcare ecosystem & evidence
Collaborations supporting localisation, specialty-care pathways, evidence generation and responsible scale in Saudi Arabia.
Investor / strategic capital
Qualified conversations with investors and strategic capital partners interested in Saudi HealthTech, specialty-care infrastructure and B2B healthcare SaaS.
Strategic Partnerships & Investor Enquiries
PACE is open to strategic collaborations that accelerate integration, programme adoption, evidence generation and scalable deployment across specialty-care ecosystems.
For investors and strategic capital partners, PACE can provide a qualified company and growth overview. Detailed market sizing, commercial pipeline, pricing, fundraising requirements, customer-sensitive information and proprietary model or architecture materials remain outside the public website and are shared through the appropriate investor process.
Bring one programme challenge. See how PACE addresses it.
Explore the workflow and insights relevant to your team, and agree which outcomes a pilot should test.
Pilot proof-of-value measures
- Time from risk signal to action
- Overdue follow-ups
- Ageing unresolved cases
- Documented resolution
- Persistence / discontinuation
- Handover completeness